Analysen zu Hermès (Hermes International)
| 27.05.25 | Hermès Outperform | Bernstein Research | |
| 12.05.25 | Hermès Outperform | RBC Capital Markets | |
| 06.05.25 | Hermès Outperform | Bernstein Research | |
| 02.05.25 | Hermès Overweight | Barclays Capital | |
| 24.04.25 | Hermès Outperform | Bernstein Research | |
| 23.04.25 | Hermès Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.04.25 | Hermès Verkaufen | DZ BANK | |
| 17.04.25 | Hermès Buy | Deutsche Bank AG | |
| 17.04.25 | Hermès Buy | Jefferies & Company Inc. | |
| 17.04.25 | Hermès Buy | UBS AG | |
| 11.04.25 | Hermès Buy | UBS AG | |
| 09.04.25 | Hermès Buy | Deutsche Bank AG | |
| 08.04.25 | Hermès Neutral | JP Morgan Chase & Co. | |
| 08.04.25 | Hermès Buy | Jefferies & Company Inc. | |
| 03.04.25 | Hermès Buy | UBS AG | |
| 28.03.25 | Hermès Outperform | Bernstein Research | |
| 28.03.25 | Hermès Buy | UBS AG | |
| 27.03.25 | Hermès Verkaufen | DZ BANK | |
| 25.03.25 | Hermès Neutral | JP Morgan Chase & Co. | |
| 17.03.25 | Hermès Neutral | JP Morgan Chase & Co. | |
| 14.03.25 | Hermès Neutral | JP Morgan Chase & Co. | |
| 04.03.25 | Hermès Outperform | Bernstein Research | |
| 18.02.25 | Hermès Verkaufen | DZ BANK | |
| 17.02.25 | Hermès Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.02.25 | Hermès Buy | UBS AG | |
| 17.02.25 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 17.02.25 | Hermès Neutral | JP Morgan Chase & Co. | |
| 14.02.25 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 14.02.25 | Hermès Outperform | Bernstein Research | |
| 14.02.25 | Hermès Buy | Jefferies & Company Inc. | |
| 14.02.25 | Hermès Buy | UBS AG | |
| 16.01.25 | Hermès Outperform | Bernstein Research | |
| 13.01.25 | Hermès Buy | UBS AG | |
| 13.01.25 | Hermès Neutral | JP Morgan Chase & Co. | |
| 10.01.25 | Hermès Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.01.25 | Hermès Buy | UBS AG | |
| 06.12.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 03.12.24 | Hermès Buy | UBS AG | |
| 02.12.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 30.10.24 | Hermès Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 25.10.24 | Hermès Halten | DZ BANK | |
| 25.10.24 | Hermès Buy | UBS AG | |
| 25.10.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 24.10.24 | Hermès Buy | UBS AG | |
| 24.10.24 | Hermès Hold | Deutsche Bank AG | |
| 24.10.24 | Hermès Buy | Jefferies & Company Inc. | |
| 07.10.24 | Hermès Buy | Jefferies & Company Inc. | |
| 07.10.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 02.10.24 | Hermès Hold | Deutsche Bank AG | |
| 24.09.24 | Hermès Buy | UBS AG |
Aktuelle Aktienanalysen
| 04.11.25 | Nemetschek Verkaufen | DZ BANK | |
| 04.11.25 | BP Kaufen | DZ BANK | |
| 04.11.25 | HUGO BOSS Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | SAF-HOLLAND Kaufen | DZ BANK | |
| 04.11.25 | BP Sector Perform | RBC Capital Markets | |
| 04.11.25 | Ferrari Hold | Jefferies & Company Inc. | |
| 04.11.25 | Linde Kaufen | DZ BANK | |
| 04.11.25 | Raiffeisen | Barclays Capital | |
| 04.11.25 | Ferrari Outperform | Bernstein Research | |
| 04.11.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Ferrari Outperform | RBC Capital Markets | |
| 04.11.25 | Boeing Outperform | RBC Capital Markets | |
| 04.11.25 | Ryanair Overweight | Barclays Capital | |
| 04.11.25 | Vossloh Hold | Warburg Research | |
| 04.11.25 | AXA Buy | Goldman Sachs Group Inc. | |
| 04.11.25 | Novartis Neutral | UBS AG | |
| 04.11.25 | HUGO BOSS Neutral | UBS AG | |
| 04.11.25 | Scout24 Neutral | UBS AG | |
| 04.11.25 | Schaeffler Neutral | UBS AG | |
| 04.11.25 | Rolls-Royce Buy | UBS AG | |
| 04.11.25 | Nemetschek Neutral | UBS AG | |
| 04.11.25 | Evonik Neutral | UBS AG | |
| 04.11.25 | Befesa Hold | Deutsche Bank AG | |
| 04.11.25 | WACKER CHEMIE Hold | Deutsche Bank AG | |
| 04.11.25 | GSK Hold | Deutsche Bank AG | |
| 04.11.25 | Ryanair Buy | Deutsche Bank AG | |
| 04.11.25 | SAF-HOLLAND Buy | Warburg Research | |
| 04.11.25 | WACKER CHEMIE Buy | Warburg Research | |
| 04.11.25 | Volkswagen Buy | Warburg Research | |
| 04.11.25 | Evonik Hold | Warburg Research | |
| 04.11.25 | BP Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Schaeffler Buy | Warburg Research | |
| 04.11.25 | HUGO BOSS Buy | Warburg Research | |
| 04.11.25 | AT & S buy | Erste Group Bank | |
| 04.11.25 | Philips Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Befesa Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 04.11.25 | Schaeffler Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | Nordex Underperform | RBC Capital Markets | |
| 04.11.25 | Schaeffler Hold | Jefferies & Company Inc. | |
| 04.11.25 | Fresenius Medical Care Sell | UBS AG | |
| 04.11.25 | Apple Neutral | UBS AG | |
| 04.11.25 | NORMA Group Add | Baader Bank | |
| 04.11.25 | HUGO BOSS Hold | Jefferies & Company Inc. | |
| 04.11.25 | HUGO BOSS Neutral | JP Morgan Chase & Co. | |
| 04.11.25 | HUGO BOSS Outperform | RBC Capital Markets | |
| 04.11.25 | Fresenius Medical Care Underperform | Jefferies & Company Inc. | |
| 04.11.25 | Philips Buy | UBS AG | |
| 04.11.25 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
| 04.11.25 | Evonik Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Nemetschek Underweight | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.